NKGen Biotech, Inc. Common Stock
NKGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $26 | $117 | $351 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $24 | $26 | $96 | $67 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $1,878 | $137 | $194 |
| Total Curr. Assets | $24 | $1,930 | $350 | $612 |
| Property Plant & Equip (Net) | $0 | $14,459 | $15,883 | $17,369 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $92 | $97 | $89 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $14,551 | $15,980 | $17,458 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $24 | $16,481 | $16,330 | $18,070 |
| Liabilities | – | – | – | – |
| Payables | $0 | $11,040 | $975 | $1,714 |
| Short-Term Debt | $0 | $9,991 | $12,034 | $51,611 |
| Tax Payable | $0 | $0 | $181 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $18,421 | $1,551 | $2,418 |
| Total Curr. Liab. | $0 | $39,452 | $14,741 | $55,743 |
| LT Debt | $0 | $9,930 | $0 | $360 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $33 | $26 | $19 |
| Other NC Liab. | $0 | $25,759 | $0 | $0 |
| Total NC Liab. | $0 | $35,722 | $26 | $379 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $379 | $818 |
| Total Liabilities | $0 | $75,174 | $14,767 | $56,122 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $2 | $1 | $14 |
| Retained Earnings | $0 | -$162,130 | -$79,176 | -$52,422 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $103,435 | $80,738 | $14,356 |
| Total Equity | $0 | -$58,693 | $1,563 | -$38,052 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $24 | $16,481 | $16,330 | $18,070 |
| Net Debt | $0 | $19,895 | $11,917 | $51,620 |